| PERIOD ENDING | 30-Sep-05 | 30-Jun-05 | 31-Mar-05 | 31-Dec-04 | | Total Revenue | 1,278 | 1,140 | 420 | 274 | | Cost of Revenue | 3,259 | 732 | 455 | (36) | | | Gross Profit | (1,981) | 408 | (35) | 311 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 33,757 | 54,435 | 163,571 | 54,166 | | Non Recurring |
-
|
-
|
-
| 56 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (35,739) | (54,027) | (163,606) | (53,911) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (166) | (370) | (2) | (2,029) | | Earnings Before Interest And Taxes | (35,905) | (54,397) | (163,609) | (55,940) | | Interest Expense | 8,634 | 1,949 | 150 | (8) | | Income Before Tax | (44,539) | (56,346) | (163,758) | (55,932) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (44,539) | (56,346) | (163,758) | (55,932) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (44,539) | (56,346) | (163,758) | (55,932) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($44,539) | ($56,346) | ($163,758) | ($55,932) |
|
0.20% Nasdaq 
Income Statement
